Intercept Pharmaceuticals, INC.
SEC CIK 1270073 · ICPT · last insider filing 2023-11-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bradbury Daniel | Director | filed 2016 - 2023 |
| Akkaraju Srinivas | Director | filed 2012 - 2023 |
| Santini Gino | Director | filed 2015 - 2023 |
| Sblendorio Glenn | Director | filed 2014 - 2023 |
| Fundaro Paolo | Director | filed 2012 - 2023 |
| Pruzanski Mark | Director · See Remarks | filed 2012 - 2023 |
| Luca Benatti | Director | filed 2014 - 2023 |
| Gottesdiener Keith Michael | Director | filed 2016 - 2023 |
| Rosa-Bjorkeson Dagmar | Director | filed 2021 - 2023 |
| Durso Jerome Benedict | Director · President & CEO | filed 2017 - 2023 |
| Miller-Rich Nancy | Director | filed 2018 - 2023 |
| Welch Daniel G | Director | filed 2015 - 2020 |
| Silverstein Jonathan | Director | filed 2012 - 2015 |
| Veitinger Klaus R DR | Director | filed 2012 - 2015 |
| Williams Nicole | Director | filed 2012 - 2015 |
| Isaly Samuel D | Director | filed 2012 - 2015 |
| Orbimed Advisors LLC | Director | filed 2012 - 2015 |
| Orbimed Capital GP IV LLC | Director | filed 2012 - 2015 |
| Patel Sanj K | Director | filed 2014 - 2014 |
| Tallarigo Lorenzo | Director | filed 2012 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Berrey M Michelle | President, R&D and CMO | filed 2021 - 2023 |
| Richardson Linda M | EVP & Chief Commercial Officer | filed 2021 - 2023 |
| Saik Andrew | EVP & Chief Financial Officer | filed 2021 - 2023 |
| Ford David A | Chief Human Resources Officer | filed 2017 - 2023 |
| Freedberg Jared | General Counsel and Secretary | filed 2021 - 2023 |
| Venezia Rocco | Chief Accounting Officer | filed 2021 - 2023 |
| Ball Bryan | Chief Quality Officer | filed 2021 - 2022 |
| Cawkwell Gail | SVP, Med Affairs, Safety & PV | filed 2018 - 2022 |
| Defrancesco Lisa | SVP, IR & Corp. Affairs | filed 2021 - 2022 |
| Weyer Christian | EVP, Research & Development | filed 2017 - 2021 |
| Kapadia Sandip | Chief Financial Officer | filed 2016 - 2021 |
| Campagna Jason | Chief Medical Officer | filed 2019 - 2021 |
| Kim Richard J | SVP, Commercial US | filed 2017 - 2021 |
| Sullivan Ryan T | General Counsel and Secretary | filed 2018 - 2020 |
| Morrison Lisa | See Remarks | filed 2015 - 2020 |
| Shapiro David | SEE REMARKS | filed 2012 - 2019 |
| Mcminn Rachel | Chief Strategy Officer | filed 2014 - 2017 |
| Duncan Barbara Gayle | Chief Financial Officer | filed 2012 - 2016 |
| Adorini Luciano | See Remarks | filed 2012 - 2016 |
| Regan Daniel Paul | Chief Commerical Officer | filed 2013 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.